how much does mochi tirzepatide cost sdrx Looks like competition is driving down prices. just announced $275 any dose Mochi Health vs Hers for

The supply agreement is designed to support the evaluation of Immuneerings lead candidate, atebimetinib (IMM-1-104), a novel dual MEK inhibitor, in combination with olomorasib in a planned Phase II trial in patients with locally advanced or metastatic KRAS G12c-mutant non-small cell lung cancer (NSCLC) who have progressed on prior therapy

Vaz et al., 2001

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

Its also less expensive

The three hormone receptors that it targets include glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors

So I would say the one big takeaway I have is that, you know, at GHLF, we do extraordinary amount of research, both on clinical research and also policy and economic research